Ohr Pharmaceutical, Inc. (OHRP)

[grich1]

From August CC which should be a nice catalyst into 2018.
Over the next several months we expect to continue our active ongoing discussions with potential partners in preparation for the data readout. We are also spending a lot of time meeting with investors throughout the United States, as well as internationally to update them on our progress, outline expectations for the MAKO study readout and walk through our strategic plan moving forward.

....to complete, analyze and report topline data from the study by early in calendar 2018, almost a year earlier than previously planned. I'm happy to report that we remain on track for the topline data readout.